Dr. Elia Sechi, an expert in autoimmune neurology and consultant at the University Hospital of Sassari, dives into the complexities of AQP4-NMOSD and MOGAD. He discusses the critical features that differentiate these conditions from MS. The importance of accurate diagnostics through advanced MRI techniques is underscored, along with innovative treatment options on the horizon. Dr. Sechi also explores acute management strategies for patients and the promising future of therapies targeting FCR and complement inhibitors.